Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 35.76 ($0.48) and traded as low as GBX 24 ($0.32). Beximco Pharmaceuticals shares last traded at GBX 25.60 ($0.34), with a volume of 63,764 shares.
Beximco Pharmaceuticals Trading Up 6.7 %
The company has a debt-to-equity ratio of 14.73, a current ratio of 1.80 and a quick ratio of 0.37. The company has a market capitalization of £114.20 million, a P/E ratio of 365.71 and a beta of 0.64. The firm has a fifty day moving average price of GBX 30.70 and a 200-day moving average price of GBX 35.76.
About Beximco Pharmaceuticals
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
See Also
- Five stocks we like better than Beximco Pharmaceuticals
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- What Is WallStreetBets and What Stocks Are They Targeting?
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Breakout Stocks: What They Are and How to Identify Them
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
